GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GlaxoSmithKline PLC's cash flow for dividends for the three months ended in Jun. 2014 was $-1,875 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Jun. 2014 was $-6,228 Mil.
Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.
GlaxoSmithKline PLC's quarterly payment of dividends increased from Dec. 2013 ($-1,041 Mil) to Mar. 2014 ($-1,524 Mil) and increased from Mar. 2014 ($-1,524 Mil) to Jun. 2014 ($-1,875 Mil).
GlaxoSmithKline PLC's annual payment of dividends increased from Dec. 2011 ($-5,652 Mil) to Dec. 2012 ($-6,366 Mil) but then declined from Dec. 2012 ($-6,366 Mil) to Dec. 2013 ($-6,063 Mil).
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
GlaxoSmithKline PLC Cash Flow for Dividends for the trailing twelve months (TTM) ended in Jun. 2014 was -1787.43961353 (Sep. 2013 ) + -1041.18616145 (Dec. 2013 ) + -1524.2881072 (Mar. 2014 ) + -1875.42662116 (Jun. 2014 ) = $-6,228 Mil.
GlaxoSmithKline PLC Annual Data
GlaxoSmithKline PLC Quarterly Data